Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally.
Alkermes stock last closed at $29.83, down 3.09% from the previous day, and has increased 20.23% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.56 percentage points. Alkermes stock is currently +30.26% from its 52-week low of $22.90, and -18.16% from its 52-week high of $36.45.
There are currently 164.9M shares of ALKS outstanding. The market capitalization of ALKS is $4.92B. In the last 24 hours, 2.21M ALKS shares were traded.
How to Buy Alkermes Stock
Not sure how to invest in Alkermes stock? Here's how.
Figure out where to buy Alkermes stock: You need to pick a stock brokerage, but don't worry - we've analyzed dozens of online stock brokerages and apps to help you determine where to buy Alkermes stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
Deposit money your investment account: Choose your method of payment and add your info.
Research Alkermes stock: The Alkermes ticker symbol is ALKS. Is Alkermes stock a good investment? Should you buy shares of ALKS? How do ALKS's underlying business fundamentals look? Do top analysts think Alkermes is a good buy? Why has ALKS's stock price moved recently? (Hint: Our stock market research tools can help you decide if ALKS is a good stock to buy).
Place your ALKS purchase: Decide if you will purchase ALKS shares at the current market price or use a limit order to purchase ALKS shares at a specific price.
Get notifications regarding your ALKS investment: Create a watchlist to key updates about your investment in Alkermes stock.
Step 1: Figure out where to buy Alkermes stock
You will need a brokerage account to access the NASDAQ market and buy ALKS stock.
A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our experience, eToro is the best online stock brokerage. Here's why:
Invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world financial markets: From Technology to Utilities, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked your brokerage, it's time to fill out some personal info so you are able to invest in ALKS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Alkermes stock
After you have chosen the best place to buy Alkermes stock, it's very important to evaluate their stock before you invest, so you actually wrap your head around the risk and opportunity.
Alkermes stock data
ALKS Price
$29.83
1w %
-5.93%
1y %
20.23%
5y %
82.78%
P/E
13.87x
P/B
3.25x
P/S
3.22x
PEG
N/A
Revenue
$1.51B
Earnings
$352.71M
Fore. Rev. Growth
-2.79%
Fore. Earn. Growth
-16.77%
Market Cap
$4.92B
Next Earnings
Jul 22, 2025
Next Dividend
N/A
ALKS Due Diligence Checks
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis.
ALKS earnings of $435.98M is not enough to cover its interest payments.
There are more short-term assets than long-term liabilities on the ALKS balance sheet.
ALKS's operating cash flow of $516.83M allows it to safely service it's debt of $74.10M.
Total ALKS debt is lower than 5 years ago, relative to shareholder equity.
There are more short-term assets than short-term liabilities on the ALKS balance sheet.
ALKS has a low debt to equity ratio of 0.38.
Negative Health Checks:
ALKS profit margin has gone down from 25.2% to 23.3% in the past year.
Do Wall Street analysts think it's a good time to buy ALKS stock
Out of 7 sell side analysts who give ratings on ALKS, the consensus analyst rating on ALKS is a Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Most Recent ALKS Analyst Upgrades/Downgrades
Chris Shibutani, a top 29% analyst from Goldman Sachs maintains ALKS with a strong buy rating and raises their ALKS price target from $30.00 to $32.00, on Feb 14, 2025.
Douglas Tsao, a bottom 1% analyst from HC Wainwright & Co. reiterates ALKS with a hold rating and maintains their ALKS price target from $46.00 to $46.00, on Feb 13, 2025.
Last year, ALKS earnings were $352.71M. Over the past 1 years, ALKS's earnings have grown by -17.94% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 6.39%.
Last year, ALKS revenue was $1.51B. During the last five year, ALKS's revenue has gone up by 4.86% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 9.6%.
In the last 12 months, insiders at ALKS have sold more shares than they have bought.
Christian Todd Nichols, SVP Chief Commercial Officer of ALKS, was the latest ALKS insider to sell. They sold $103,654.06 worth of ALKS shares on Jun 10, 2025.
No, Alkermes doesn't provide an income stream by paying out dividends.
What others are saying about ALKS
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your ALKS purchase
There are two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually the best for newer investors.
Limit order: A limit order enables you to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a specific price, use a limit order.
Click the Open button and eToro will execute the order.
If you want additional help buying stocks on eToro, click the helpful video below:
As of Jun 13, 2025, it costs $29.83 to buy one share of Alkermes stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.335 shares of ALKS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.